Status:

COMPLETED

Brain Mechanisms Underlying the Effect of the Motilin Receptor Agonist Erythromycin on Hunger in Normal Weight Subjects

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Collaborating Sponsors:

KU Leuven

Conditions:

Healthy Volunteers

Eligibility:

FEMALE

18-60 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to investigate the role of erythromycin, a prokinetic agent, on hunger, and the brain mechanism lying behind it.

Eligibility Criteria

Inclusion

  • Female only.
  • Age \> 18 and \< 60.
  • Body Mass Index (BMI) of 19-25 kg/m2 (no weight change of more than 5 kg in the past three months).
  • Not known to have any chronic medical illness or illnesses affecting the gastrointestinal, cardiovascular, or nervous systems, chronic pain or psychiatric disorder.
  • If female not known to be pregnant.
  • Not known to have any past upper gastrointestinal surgery.

Exclusion

  • Alcohol consumption \> 7 drinks / week
  • Major depression and chronic health conditions except controlled hypertension

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT02212821

Start Date

September 1 2014

Last Update

November 30 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Brain Mechanisms Underlying the Effect of the Motilin Receptor Agonist Erythromycin on Hunger in Normal Weight Subjects | DecenTrialz